| Titolo | Pubblicato in | Anno |
|---|---|---|
| Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint | CURRENT NEUROPHARMACOLOGY | 2021 |
| ADEM after ChAdOx1 nCoV-19 vaccine: A case report | MULTIPLE SCLEROSIS | 2021 |
| Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies | EBIOMEDICINE | 2021 |
| Enrichment analysis of GWAS data in autoimmunity delineates the multiple sclerosis-Epstein Barr virus association | biorXiv | 2021 |
| Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis | GENES | 2020 |
| SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets | F1000RESEARCH | 2020 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma
